Movano (NASDAQ:MOVE) Rating Increased to Hold at Wall Street Zen

Movano (NASDAQ:MOVE) was upgraded by analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a note issued to investors on Saturday.

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Movano in a research report on Thursday, January 22nd. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company has a consensus rating of “Sell”.

Movano Stock Down 1.0%

Shares of MOVE stock opened at $11.40 on Friday. The company has a market capitalization of $13.00 million, a PE ratio of -1.05 and a beta of 0.81. Movano has a 12-month low of $4.67 and a 12-month high of $49.76. The firm has a 50 day moving average price of $10.81 and a two-hundred day moving average price of $8.83.

Insider Buying and Selling at Movano

In other Movano news, CEO John Mastrototaro sold 33,069 shares of the company’s stock in a transaction on Tuesday, January 27th. The shares were sold at an average price of $20.80, for a total transaction of $687,835.20. Following the sale, the chief executive officer owned 56,114 shares of the company’s stock, valued at approximately $1,167,171.20. This represents a 37.08% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CFO Jeremy Cogan sold 28,736 shares of Movano stock in a transaction that occurred on Tuesday, January 27th. The stock was sold at an average price of $20.78, for a total value of $597,134.08. Following the completion of the sale, the chief financial officer owned 60,504 shares of the company’s stock, valued at approximately $1,257,273.12. The trade was a 32.20% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last ninety days, insiders sold 94,383 shares of company stock worth $1,524,933. 10.40% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Movano stock. Citadel Advisors LLC purchased a new position in Movano Inc. (NASDAQ:MOVE) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 49,262 shares of the technology company’s stock, valued at approximately $28,000. Citadel Advisors LLC owned 5.94% of Movano at the end of the most recent quarter. 16.64% of the stock is currently owned by institutional investors.

Key Stories Impacting Movano

Here are the key news stories impacting Movano this week:

• Positive Sentiment: Technical backdrop: the 50‑day simple moving average sits above the 200‑day average (50‑day $10.75 vs 200‑day $8.79), which can support the medium‑term trend and act as a stabilizer for the stock. See Movano price data. MarketBeat: MOVE price
• Neutral Sentiment: No company-specific news in the supplied articles — no earnings, guidance, deals or FDA/clinical updates that would explain a material re‑rating; absence of catalysts makes small‑cap names prone to noise-driven moves.
• Neutral Sentiment: Macro and market headlines in the feed (Fed/DOJ legal developments and market‑wide volatility signals) can drive risk‑off flows into or out of microcaps; these are indirect and hard to quantify. Benzinga coverage of the Fed/DOJ story is an example. Federal Reserve legal story
• Neutral Sentiment: Cryptocurrency and macro‑risk stories in the feed (Bitcoin/XRP volatility) are pushing intraday sentiment across speculative sectors; this can increase trading dispersion and promote profit‑taking in small, illiquid stocks. Example coverage of bitcoin momentum. Bitcoin momentum
• Negative Sentiment: Extremely low trading volume versus its 3‑month average (the feed notes today’s volume far below average) and a very small market cap (~$13M) make MOVE susceptible to outsized intraday swings and limited liquidity — sellers can move the price more easily on thin order books.
• Negative Sentiment: Fundamentals/risk profile: negative trailing P/E (losses) and a wide 52‑week range indicate elevated execution and valuation risk for investors; absent fresh positive catalysts, investors often de‑risk these microcaps.

About Movano

Movano Health, Inc (NASDAQ: MOVE) is a health technology company focused on developing wearable devices for continuous biometric monitoring. The company’s core mission is to provide accessible, real-time health insights through noninvasive sensors, enabling individuals and care teams to track vital signs and physiological trends outside of traditional clinical settings.

Movano’s flagship product is a biometric monitoring ring designed to measure parameters such as heart rate, blood oxygen saturation, skin temperature, and sleep quality.